🇺🇸 FDA
Pipeline program

Pioglitazone

CP-PENQEX-1R21AA017271

Phase 2 small_molecule completed

Quick answer

Pioglitazone for Chronic Pancreatitis is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Chronic Pancreatitis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials